From the Dallas Plastic Surgery Institute; and the Department of Plastic Surgery, Loma Linda University Medical Center.
Plast Reconstr Surg. 2021 Apr 1;147(4):607e-612e. doi: 10.1097/PRS.0000000000007750.
The purpose of this special topic article is to present an evidence-based approach and provide recommendations for the management of both asymptomatic and symptomatic patients with textured surface breast implants. There are currently no scientific data to support complete removal of a benign capsule. When unnecessary capsulectomies are performed, the patient is at higher risk for developing postoperative complications. Ultimately, the decision to keep, exchange, or remove breast implants is the patient's decision and the procedure should be performed only by a qualified surgeon.
本专题文章旨在提供一种基于循证医学的方法,并为有症状和无症状的表面纹理乳房植入物患者的管理提供建议。目前尚无科学数据支持完整切除良性包膜。当进行不必要的包膜切除术时,患者发生术后并发症的风险更高。最终,保留、更换或取出乳房植入物的决定是患者的决定,并且该手术应由合格的外科医生进行。